{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T12:42:17Z","timestamp":1794660137409,"version":"4.9.1"},"reference-count":16,"publisher":"Knowledge E DMCC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ophthalmic Vis Res"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/jovr.jovr_46_16","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T07:25:35Z","timestamp":1509348335000},"page":"429","source":"Crossref","is-referenced-by-count":5,"title":["Severe rosacea: A case report"],"prefix":"10.18502","volume":"12","author":[{"given":"Abbas","family":"Bagheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Shirzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MojtabaFattahi","family":"Abdizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MozhganRezaei","family":"Kanavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7770","reference":[{"key":"key-10.4103\/2008-322X.216390-1","first-page":"107","volume-title":"Systematic review of rosacea treatments.J Am Acad Dermatol","author":"van","year":"2007","journal-title":""},{"key":"key-10.4103\/2008-322X.216390-2","first-page":"S27","volume-title":"Rosacea: Current state of epidemiology.J Am Acad Dermatol","author":"Tan","year":"2013","journal-title":""},{"key":"key-10.4103\/2008-322X.216390-3","first-page":"379","volume-title":"Face-to-face with anti-inflammatory therapy for rosacea.Exp Dermatol","author":"Salzer","year":"2014","journal-title":""},{"key":"key-10.4103\/2008-322X.216390-4","doi-asserted-by":"crossref","unstructured":"Dessinioti C, Antoniou C. Systemic Treatment of Rosacea. In: Zouboulis CC, Katsambas AD, Kligman AM, editors. Pathogenesis and Treatment of Acne and Rosacea: Springer Berlin Heidelberg; 2014. p. 699-705.","DOI":"10.1007\/978-3-540-69375-8_93"},{"key":"key-10.4103\/2008-322X.216390-5","first-page":"S179","volume-title":"Epidemiology of rosacea: updated data","author":"Chosidow","year":"2011","journal-title":"Ann Dermatol Venereol"},{"key":"key-10.4103\/2008-322X.216390-6","first-page":"33","volume-title":"Papulopustular rosacea: Prevalence and relationship to photodamage.J Am Acad Dermatol","author":"McAleer","year":"2010","journal-title":""},{"key":"key-10.4103\/2008-322X.216390-7","first-page":"13","volume-title":"Clinical evaluation of Libyan patients with rosacea and its correlation with seropositivity to Helicobacter pylori","author":"El-Sherif","year":"38;","journal-title":"Journal of Dermatology"},{"key":"key-10.4103\/2008-322X.216390-8","doi-asserted-by":"crossref","unstructured":"Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51:327-341.","DOI":"10.1016\/j.jaad.2004.03.030"},{"key":"key-10.4103\/2008-322X.216390-9","first-page":"171","volume-title":"The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent FacialErythema Associated with Rosacea","author":"Johnson","year":"2015","journal-title":"Dermatol Ther (Heidelb)"},{"key":"key-10.4103\/2008-322X.216390-10","first-page":"584","volume-title":"Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea.J Am Acad Dermatol","author":"Wilkin","year":"2002","journal-title":""},{"key":"key-10.4103\/2008-322X.216390-11","first-page":"Nature Publishing Group","volume-title":", editors.Clinical, cellular, and molecular aspects in the pathophysiology of rosacea","author":"Steinhoff","year":"2011","journal-title":"Journal of Investigative Dermatology Symposium Proceedings;"},{"key":"key-10.4103\/2008-322X.216390-12","first-page":"1336","volume-title":"Rosacea under the microscope: Characteristic histological findings.J Eur Acad Dermatol Venereol","author":"Cribier","year":"2013","journal-title":""},{"key":"key-10.4103\/2008-322X.216390-13","first-page":"92","volume-title":"Rosacea and its ocular manifestations","author":"Oltz","year":"2011","journal-title":"Optometry"},{"key":"key-10.4103\/2008-322X.216390-14","first-page":"35","volume-title":"Rosacea and rhinophyma","author":"T\u00fcz\u00fcn","year":"2014","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2008-322X.216390-15","first-page":"587","volume-title":"Rosacea: An update","author":"McDonnell","year":"2000","journal-title":"Cleve Clin J Med"},{"key":"key-10.4103\/2008-322X.216390-16","first-page":"1","volume-title":"Antinuclear antibodies in rosacea patients.Advances in Dermatology and Allergology\/Post\u0229py Dermatologii I Alergologii","author":"Wo\u017aniacka","year":"2013","journal-title":""}],"container-title":["Journal of Ophthalmic and Vision Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T14:57:18Z","timestamp":1734447438000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jovr.org\/text.asp?2017\/12\/4\/429\/216390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"alternative-id":["216390"],"URL":"https:\/\/doi.org\/10.4103\/jovr.jovr_46_16","relation":{},"ISSN":["2008-322X"],"issn-type":[{"value":"2008-322X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}